Leveraging Combination Checkpoint Inhibitors to Regulate Immunological Responses & “Flip” the Tumor Microenvironment
Time: 11:45 am
day: Conference Day 1
Details:
- Examining the molecular pathways which modulate T-cell activation and immune response in the GBM tumor microenvironment
- Reprogramming the tumor microenvironment by enhancing cytotoxic T-cell infiltration and reducing regulatory T-cell activity within GBM, effectively “flipping” the tumor microenvironment
- Investigating synergistic effects in combination therapies with the potential of combining checkpoint inhibitors with other immunotherapies or standard treatments to amplify anti tumor efficacy and overcome immune resistance in GBM
